worldwiki
医疗 · Plastic Surgery

Breast Revision Surgery

别名: breast implant removal, explant, 가슴 재수술

发布 2026年9月14日更新 2026年9月20日
来自本站服务器日志的请求记录,爬虫身份通过反向 DNS 或 IP 段核验。Google12Anthropic1OpenAI1首次采集 2026年9月15日最近请求Google2026年9月20日Google2026年9月20日Google2026年9月20日Google2026年9月20日Google2026年9月20日OpenAI2026年9月20日Google2026年9月19日Google2026年9月19日Google2026年9月19日Google2026年9月19日Google2026年9月19日Google2026年9月19日
请求更正
语言English尚未翻译为该语言,此处显示英文原文。
定义

Breast revision surgery corrects or changes the result of a previous breast augmentation, such as implant removal, replacement or fat grafting after implants.

快速回答

What is breast revision surgery?

Breast revision surgery corrects or changes the result of a previous breast augmentation. Common reasons are capsular contracture, implant rupture, position or size change and personal preference. Options include implant replacement, implant removal with or without a lift, and fat grafting after implant removal. Revision is generally more complex than the original surgery.

已验证 2026年9月15日

关键事实

属性来源
Implant removal methodsImplant removed alone with the scar capsule left in place, or implant removed with part or all of the capsule (en bloc resection is the more extensive option)截至 2023年12月15日[2]governmentRisks and Complications of Breast ImplantsU.S. Food and Drug Administration
Implant lifespan (FDA position)Breast implants are not considered lifetime devices; the longer they are in place, the greater the chance of complications截至 2023年12月15日[2]governmentRisks and Complications of Breast ImplantsU.S. Food and Drug Administration
Insurance coverage (US)Some insurers do not cover implant removal or replacement, even when there are complications截至 2023年12月15日[2]governmentRisks and Complications of Breast ImplantsU.S. Food and Drug Administration
Screening for silent ruptureMRI is the most effective method; ultrasound is an acceptable alternative截至 2023年12月15日[2]governmentRisks and Complications of Breast ImplantsU.S. Food and Drug Administration
Surgical management of confirmed BIA-ALCLComplete removal of the implant with the intact surrounding capsule (en bloc capsulectomy); some cases also need chemotherapy or radiation[3]journalRecognizing and Managing Breast Implant Complications: A Review for Healthcare Providers Who Treat Women Who Underwent Breast Implant–Based SurgeryInternational Journal of Women's Health (via PubMed Central)
MFDS position on preventive removal (Korea)Preventive removal is not recommended for patients without symptoms; patients with suspected and confirmed BIA-ALCL are registered for tracking[4]government[안전성정보] 식약처, 유방보형물 이식환자 안전관리 대책 마련식품의약품안전처
Korean recall of textured implantsMFDS recalled Allergan textured breast implants and advised a halt to their use over a possible BIA-ALCL link截至 2019年8月4日[5]news식약처, 엘러간 인공유방 회수… "희귀암 유발 가능성"한국일보
Share of revisions due to capsular contracture (registries)25.0–36.7 (Swedish, Australian and Dutch registry data) %[3]journalRecognizing and Managing Breast Implant Complications: A Review for Healthcare Providers Who Treat Women Who Underwent Breast Implant–Based SurgeryInternational Journal of Women's Health (via PubMed Central)
Share of revisions due to rupture (registries)12.2–23.4 (Swedish, Australian and Dutch registry data) %[3]journalRecognizing and Managing Breast Implant Complications: A Review for Healthcare Providers Who Treat Women Who Underwent Breast Implant–Based SurgeryInternational Journal of Women's Health (via PubMed Central)
10-year silicone implant rupture rate after revision augmentation5.2 (compared with 7.8 for primary augmentation and 9.8 for primary reconstruction) %[3]journalRecognizing and Managing Breast Implant Complications: A Review for Healthcare Providers Who Treat Women Who Underwent Breast Implant–Based SurgeryInternational Journal of Women's Health (via PubMed Central)
Evidence for routine capsulectomyA 2021 review argues there is no evidence that removing the capsule during implant replacement lowers later BIA-ALCL or breast implant illness risk, and notes higher surgical risk; this is one author's view[6]journalThe Case for Breast Implant Removal or Replacement Without CapsulectomyAesthetic Plastic Surgery (Swanson E.), via PubMed Central
Common reasonsCapsular contracture, rupture, position or size change, personal preference[1]organizationBreast Implant RemovalAmerican Society of Plastic Surgeons

概述

Breast revision surgery is a second or later operation on a breast that has already had surgery. It is most often done to fix implant problems after augmentation or reconstruction. It may include removing the implant (explantation), with or without cutting the scar capsule around it (capsulotomy) or removing part or all of it (partial, total or en bloc capsulectomy). It may also include exchanging the implant or adding a breast lift (mastopexy) or fat grafting. The US FDA states that breast implants are not lifetime devices and that the chance of complications needing more surgery rises over time. Confirmed BIA-ALCL is treated by removing the implant together with its capsule. Neither the FDA nor Korea's MFDS recommends routine preventive removal in people without symptoms. Readers should check the surgeon's credentials, the implant's make and surface type, imaging results and insurance coverage.

已验证服务机构

付费展示均有标注。验证与付费无关。
已验证

SC301의원

SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.

查看机构

参考来源

独立来源比例 100% (9/9)
等级 A · 3等级 B · 2等级 C · 3等级 D · 1
  1. 等级 C · organizationBreast Implant RemovalAmerican Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
  2. 等级 A · governmentRisks and Complications of Breast ImplantsU.S. Food and Drug Administration · 访问于 2026年9月19日 · 证据页
  3. 等级 B · journalRecognizing and Managing Breast Implant Complications: A Review for Healthcare Providers Who Treat Women Who Underwent Breast Implant–Based SurgeryInternational Journal of Women's Health (via PubMed Central) · 访问于 2026年9月20日 · 证据页
  4. 等级 A · government[안전성정보] 식약처, 유방보형물 이식환자 안전관리 대책 마련식품의약품안전처 · 访问于 2026年9月19日 · 证据页
  5. 等级 D · news식약처, 엘러간 인공유방 회수… "희귀암 유발 가능성"한국일보 · 访问于 2026年9月20日 · 证据页
  6. 等级 B · journalThe Case for Breast Implant Removal or Replacement Without CapsulectomyAesthetic Plastic Surgery (Swanson E.), via PubMed Central · 访问于 2026年9月20日 · 证据页
  7. 等级 A · governmentBreast enlargement (implants)NHS (UK National Health Service) · 访问于 2026年9月20日 · 证据页
  8. 等级 C · organizationBreast AugmentationAmerican Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
  9. 等级 C · organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
变更历史
首次发布 · 2026年9月14日